Today: 19 May 2026
Browse Category

NASDAQ:QRVO 9 July 2025 - 26 January 2026

Qorvo stock drifts into earnings week: what to watch for QRVO before Tuesday’s report

Qorvo stock drifts into earnings week: what to watch for QRVO before Tuesday’s report

Qorvo shares fell 0.8% to $80.91 Friday ahead of its fiscal third-quarter earnings report, due after Tuesday’s close. Investors are watching for updates on handset demand, margins, and the pending Skyworks merger. About 1.5 million shares traded as the stock ranged from $80.12 to $82.10. Apple’s results Thursday could also influence sentiment on Qorvo and other suppliers.
26 January 2026
··
Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks Soars 18% on $22B Qorvo Merger – What’s Next for the Chipmaker?

Skyworks shares jumped nearly 18% to around $89 on Oct. 28 after announcing a $22 billion cash-and-stock deal to acquire Qorvo. Qorvo holders will receive $32.50 and 0.96 Skyworks shares per Qorvo share. Skyworks recently reported Q3 revenue of $965 million and non-GAAP EPS of $1.33, both above forecasts. Wall Street remains cautious, with an average 12-month target of $70.90.
28 October 2025
···
Mixed-Signal and RF Components: June–July 2025 Industry Report

Mixed-Signal and RF Components: June–July 2025 Industry Report

Mixed-Signal Devices launched the MS4022 RF synthesizer on June 16, generating 675 MHz–22 GHz with 25 fs RMS phase jitter. Falcomm and GlobalFoundries reported 50% PAE in a 13 GHz CMOS power amp. 3GPP finalized Release 20 for early 6G research on June 18. The U.S. lifted EDA tool export restrictions for China on July 3, restoring access to Synopsys, Cadence, and Siemens.
9 July 2025
········

Stock Market Today

  • U.S. Stock Futures Slide on Tech Selloff, War Concerns - May 19, 2026
    May 19, 2026, 8:53 AM EDT. U.S. stock futures declined Tuesday amid another drop in technology shares, dragging the S&P 500 and Nasdaq lower for the second day. Investor sentiment weakened on escalating geopolitical tensions, introducing war uncertainty that added pressure to risk assets. The tech selloff weighed heavily, reflecting ongoing concerns over sector valuations and potential earnings risks. Markets remained cautious as traders balanced these factors against broader economic indicators.

Latest articles

Wellgistics Health Doubles, WGRX Heads Into Key Test

Wellgistics Health Doubles, WGRX Heads Into Key Test

19 May 2026
Wellgistics Health shares fell 21.1% to $0.14 in premarket trading Tuesday after more than doubling Monday. The company delayed its quarterly report, withdrew proxy materials, and is reviewing potential strategic transactions. First-quarter results are due after the market closes. The moves follow a non-binding $15 million acquisition proposal for WellCare Today.
Roblox Stock Moves Up Early, Safety Issues Still Linger

Roblox Stock Moves Up Early, Safety Issues Still Linger

19 May 2026
Roblox shares traded at $47.41 in early New York hours Tuesday, extending gains after third-party data showed a week-over-week rise in concurrent users. Needham maintained its Buy rating and $60 target. The stock remains pressured by a lowered 2026 bookings outlook, tied to new safety and age-check measures. Roblox reported Q1 revenue of $1.4 billion and bookings of $1.7 billion.
Amer Sports Rises Premarket on Salomon Strength

Amer Sports Rises Premarket on Salomon Strength

19 May 2026
Amer Sports raised its 2026 sales, margin, and profit outlook after first-quarter revenue jumped 32% to $1.95 billion, beating forecasts. Shares rose 4.18% in premarket trading to $34.54. Adjusted earnings reached 38 cents a share, above analysts’ estimates. Growth was led by Arc’teryx, Salomon softgoods, and Wilson Tennis 360.

Popular

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Go toTop